-
Satellos Announces Dosing of First Participant in Phase 1 Clinical Study of SAT-3247 | Morningstar
ソース: Buzz FX / 18 9 2024 08:34:14 America/New_York
[Business Wire](/news/business-wire) Satellos Announces Dosing of First Participant in Phase 1 Clinical Study of SAT-3247 Satellos Announces Dosing of First Participant in Phase 1 Clinical Study of SAT-3247 - The first healthy volunteer has
Read more...